Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen.

MLA

Dobaño, Carlota, et al. “Spike-Based COVID-19 Immunization Increases Antibodies to Nucleocapsid Antigen.” Translational Research: The Journal of Laboratory & Clinical Medicine, vol. 240, Feb. 2022, pp. 26–32. EBSCOhost, https://doi.org/10.1016/j.trsl.2021.10.004.

APA

Dobaño, C., Jiménez, A., Rubio, R., Alonso, S., Ramírez-Morros, A., Vidal, M., Vidal-Alaball, J., Ruiz-Comellas, A., García-Basteiro, A. L., Izquierdo, L., Aguilar, R., & Moncunill, G. (2022). Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen. Translational Research: The Journal of Laboratory & Clinical Medicine, 240, 26–32. https://doi.org/10.1016/j.trsl.2021.10.004

Chicago

Dobaño, Carlota, Alfons Jiménez, Rocío Rubio, Selena Alonso, Anna Ramírez-Morros, Marta Vidal, Josep Vidal-Alaball, et al. 2022. “Spike-Based COVID-19 Immunization Increases Antibodies to Nucleocapsid Antigen.” Translational Research: The Journal of Laboratory & Clinical Medicine 240 (February): 26–32. doi:10.1016/j.trsl.2021.10.004.